Bo-112 drug page Clinical trials

Trials with Bo-112

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
3Countries
18Planned patients

Showing 1–1 of 1

Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Finished Phase 2 18 patients NCT04508140

This is an open, single arm, multicenter phase 2 trial in which BO-112 will be administered intratumorally in combination with intravenous pembrolizumab in patients with liver metastasis from colorectal, gastric or gastroesophageal junctio…

Belgium, Italy, Spain Jun 2020 – Dec 2022 Interventional
Combined with: Pembrolizumab